We noted that the liver injury-related markers, including decreased pre-albumin, albumin, and cholinesterase levels, were observed at the initial stages, and the intermediate stage of SARS-CoV-2 infection in severe and critical COVID-19. This evidence concerns the gene BCHE and COVID-19.